US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney Disease Progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
Medicare, Ozempic and Wegovy
Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.
Hosted on MSN15h
Lighter but weaker? The hidden costs of Ozempic and weight-loss drugs for endurance athletesOzempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
A woman died of total organ failure after she developed profound electrolyte abnormalities from vomiting while taking Ozempic ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...
Posts about unexpected pregnancies while using drugs such as Ozempic for weight loss are trending on social media. Does any scientific evidence back this up? Sangeetha Nadarajah reports Amid the ...
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback